Patients aged 10 to 17 years who are prescribed GLP-1 RAs are more likely to have comorbid type 2 diabetes and more.

Facial volume loss and increased skin laxity were significant in the mid-cheek region after major weight loss, resulting in accelerated facial aging.

Diabetes and excessive weight are independent risk factors for adult asthma that have the potential to be modified.

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

There are sex-specific differences for risk factors, hospitalization rates, and in-hospital mortality in patients with stroke.

Patients with T2D with more severe peripheral neuropathy have a 4-fold DED risk compared with patients with mild or no peripheral neuropathy.

A look into ways AI technology in cardiology is evolving & how it can be applied to patient management & care as it continues ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Most physicians adhere to guideline-directed medical therapies for HFrEF based on the 2021 European Society of Cardiology HF guidelines.

Metformin use, compared with no use, was associated with a lower risk for uterine fibroids among women with diabetes.

A study has found that video or audio-only telehealth visits are prevalent in patients with cardiovascular disease in the United States.

Early antihypertensive treatment may lead to functional dependency or death at 90 days in patients with stroke with PAD stenosis.